TACSTD2 and hepatocellular carcinoma: The role of TACSTD2 in HCV infection was confirmed by immunofluorescence using a replication-competent variant of the HCV strain JFH1 (JFH1-AM2) selected in vitro for its efficiency of replication in hepatoma cells [37].